J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 84 (2003), 475-484; DOI 10.1099/vir.0.18714-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Leeuw, O. S.
Right arrow Articles by Peeters, B. P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Leeuw, O. S.
Right arrow Articles by Peeters, B. P. H.
Agricola
Right arrow Articles by de Leeuw, O. S.
Right arrow Articles by Peeters, B. P. H.
© 2003 Society for General Microbiology

Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain

Olav S. de Leeuw1, Leo Hartog2, Guus Koch2 and Ben P. H. Peeters1

1 Department of Infectious Disease & Food Chain Quality, Institute for Animal Science and Health, PO Box 65, NL-8200 AB Lelystad, The Netherlands
2 Central Institute for Animal Disease Control, PO Box 2004, NL-8203 AA Lelystad, The Netherlands

Correspondence
Ben Peeters
b.p.h.peeters{at}id.wag-ur.nl

Virulence of Newcastle disease virus (NDV) is mainly determined by the amino acid sequence of the fusion (F0) protein cleavage site. Full-length NDV cDNA clone pNDFL was used to generate infectious NDV with defined mutations in the F0 cleavage site (RRQRR{downarrow}L, GRQGR{downarrow}F, RRQGR{downarrow}F, RGQRR{downarrow}F and RKQKR{downarrow}F). All the mutants were viable and the mutations were maintained after virus propagation in embryonated eggs. The mutants showed single-cell infections on chicken embryo fibroblasts, which suggested that they were non-virulent. However, virulence tests in 1-day-old chickens resulted in an intracerebral pathogenicity index (ICPI) between 0 and 1·3. Moreover, virulent virus was isolated from chickens that had died in the virulence tests. Subsequent sequence analysis showed that the mutants RRQRR{downarrow}L, RRQGR{downarrow}F, RGQRR{downarrow}F and RKQKR{downarrow}F gave rise to the appearance of revertants containing the virulent cleavage site RRQ(K/R)R{downarrow}F and an ICPI of 1·4 or higher. This indicated that reversion to virulence was caused by alteration of the amino acid sequence of the F0 cleavage site from a non-virulent to a virulent type. Furthermore, the ICPI of the revertants was higher than that of cDNA-derived strain NDFLtag, which has the same cleavage site, RRQRR{downarrow}F (ICPI=1·3). NDFLtagPass, which was isolated from dead chickens after intracerebral inoculation of NDFLtag, also showed an increase in the ICPI from 1·3 to 1·5. This study proves that reversion to virulence occurs within non-virulent NDV populations and that the virulence may increase after one passage in chicken brain.




This article has been cited by other articles:


Home page
CVIHome page
S.-H. Cho, H.-J. Kwon, T.-E. Kim, J.-H. Kim, H.-S. Yoo, M.-H. Park, Y.-H. Park, and S.-J. Kim
Characterization of a Recombinant Newcastle Disease Virus Vaccine Strain
Clin. Vaccine Immunol., October 1, 2008; 15(10): 1572 - 1579.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L.-T. Tan, H.-Y. Xu, Y.-L. Wang, Z.-M. Qin, L. Sun, W.-J. Liu, and Z.-Z. Cui
Molecular Characterization of Three New Virulent Newcastle Disease Virus Variants Isolated in China
J. Clin. Microbiol., February 1, 2008; 46(2): 750 - 753.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Goebel, J. Taylor, B. C. Barr, T. E. Kiehn, H. R. Castro-Malaspina, C. V. Hedvat, K. A. Rush-Wilson, C. D. Kelly, S. W. Davis, W. A. Samsonoff, et al.
Isolation of Avian Paramyxovirus 1 from a Patient with a Lethal Case of Pneumonia
J. Virol., November 15, 2007; 81(22): 12709 - 12714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Vigil, M.-S. Park, O. Martinez, M. A. Chua, S. Xiao, J. F. Cros, L. Martinez-Sobrido, S. L.C. Woo, and A. Garcia-Sastre
Use of Reverse Genetics to Enhance the Oncolytic Properties of Newcastle Disease Virus
Cancer Res., September 1, 2007; 67(17): 8285 - 8292.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-S. Park, J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese
From the Cover: Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease
PNAS, May 23, 2006; 103(21): 8203 - 8208.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
O. S. de Leeuw, G. Koch, L. Hartog, N. Ravenshorst, and B. P. H. Peeters
Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein
J. Gen. Virol., June 1, 2005; 86(6): 1759 - 1769.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. von Messling, C. Springfeld, P. Devaux, and R. Cattaneo
A Ferret Model of Canine Distemper Virus Virulence and Immunosuppression
J. Virol., December 1, 2003; 77(23): 12579 - 12591.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Romer-Oberdorfer, O. Werner, J. Veits, T. Mebatsion, and T. C. Mettenleiter
Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity
J. Gen. Virol., November 1, 2003; 84(11): 3121 - 3129.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 by the Society for General Microbiology.